ProShare Advisors
BLFS icon

ProShare Advisors’s BioLife Solutions BLFS Stock Holding History

ProShare Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,864
Closed -$282K – 2108
2024
Q4 		$282K Buy
+10,864
New +$270K ﹤0.01% 1679
2021
Q3 		– Sell
-6,333
Closed -$282K – 2036
2021
Q2 		$282K Buy
+6,333
New +$223K ﹤0.01% 1933

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

ProShare Advisors's BLFS Position: Q1 2025 in Review

ProShare Advisors sold out of BioLife Solutions (BLFS) in Q1 2025, closing a stake of 10,864 shares — an estimated $282K sold.

ProShare Advisors first reported a position in BLFS in Q2 2021 and held it in 2 quarters. The position peaked at $282K in Q4 2024. 188 funds tracked by Wall St. Rank hold BLFS as of Q1 2025.

  • ProShare Advisors reported no remaining BioLife Solutions position as of Q1 2025 after selling out during the quarter.
  • ProShare Advisors sold 10,864 BioLife Solutions shares in Q1 2025, an estimated $282K.
  • ProShare Advisors first reported a position in BioLife Solutions in Q2 2021 and held it in 2 quarters.
  • ProShare Advisors's BioLife Solutions position peaked at $282K in Q4 2024.
  • 188 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2025.

Based on ProShare Advisors's 13F filing for Q1 2025, filed 8 May 2025.